The cistrome response to hypoxia in human umbilical vein endothelial cells

  1. Department of Biological Science, Florida State University, Tallahassee, United States
  2. Department of Pharmacology, University of South Alabama College of Medicine, Mobile, United States

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Yamini Dalal
    National Cancer Institute, Bethesda, United States of America
  • Senior Editor
    Yamini Dalal
    National Cancer Institute, Bethesda, United States of America

Reviewer #1 (Public review):

Summary:

The manuscript by Singh et al. presents an application of MOA-seq to better define transcriptional control underlying the hypoxia response in human endothelial cells. This group's previously described MOA-seq technique allows for precise, identity-agnostic mapping of occupied sites of DNA-binding proteins across the epigenome and over time. Here, they applied MOA-seq to HUVECs under normal oxygen conditions or variable lengths of hypoxia treatment, comparing changes in occupancy over time and associating these changes with corresponding transcriptome alterations. This approach revealed thousands of dynamically occupied sites comprising 10 major kinetic clusters that appear to define distinct subsets and phases of the hypoxia response. Analysis of DNA motifs in these dynamically occupied regions captured the known major roles of HIF1A in the hypoxia response and also implicated new HIF1A-associated regulators. Importantly, they also identified many potential HIF1A-independent candidate TFs that act at HREs, which has been an outstanding question in the field. Additionally, this study identified ~7K additional sites not previously defined as regulatory elements by ENCODE.

Strengths:

Overall, this study is well executed and described, providing new biological insights as well as a rich data resource for the field. As MOA-seq was previously developed for use in plants, this work demonstrates the application of this method in mammalian cells and highlights its utility in identifying new potential regulatory sites not captured by DNase-seq or ATAC-seq. The conclusions made by the authors are well supported by the results, with the caveat that extensive use of DNA motif identification and ontology analyses invariably leads to some uncertainty regarding factor identity and gene network properties.

Weaknesses:

There are several areas where the clarity of presentation could be improved:

(1) Given the importance of the methodology, the methods section needs more detail on how the extent of MNase digestion is chosen to achieve optimal results with MOA-seq. This is described to some extent in the description of control library preparation, but not for the experimental samples.

(2) The abstract describes this approach as "native cistrome profiling" but this is misleading since formaldehyde fixation is used.

(3) Species- and field-specific jargon and abbreviations need to be clarified on first usage. For example, on page 9: "Downsampling analysis was carried out for two sets of published reference peaks; the CTCF cCRE peak midpoints and for the ERG motif under the ERG ReMap ChIP-seq peaks." The different categories of cCREs were not clearly defined, nor will it be clear what the term ReMap refers to for those outside the field. The sentence after this refers to IDR, which also should be defined.

(4) Figure 4C: Are these motifs examined under MOA sites specifically or anywhere in the genes in question?

(5) Figure 5B shows that up-DEGs with diff-MOA footprints tend to show more losses of footprints. Do the authors interpret this as a loss of repressor binding?

Reviewer #2 (Public review):

Summary:

Singh et al. apply MOA-seq to map transcription factor occupancy genome-wide in HUVECs across a hypoxia time course. The study provides a well-validated, high-resolution view of cistrome dynamics and identifies both HIF1A-associated and independent regulatory programs.

Major Comments:

Methodological validation is strong. MOA-seq's ability to map protein-bound DNA at near-nucleotide resolution without factor-specific antibodies is a genuine advance, and the cross-validation against independent ChIP-seq and ENCODE datasets is convincing. As noted, future work with additional biological replicates could further strengthen confidence in the smaller kinetic clusters.

Imaging-based validation would strengthen the key biological claims. The kinetic clustering and pathway enrichments are computationally inferred. Orthogonal approaches, for example, live-cell fluorescence imaging of HIF1A nuclear translocation to confirm the proposed temporal binding waves, would provide independent experimental support.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation